Michael Piccolo
Stock Analyst at Wedbush
(1.30)
# 3,720
Out of 5,238 analysts
13
Total ratings
57.14%
Success rate
-5.91%
Average return
Main Sectors:
Stocks Rated by Michael Piccolo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BUR Burford Capital | Maintains: Neutral | $4.75 → $5 | $5.14 | -2.72% | 3 | May 11, 2026 | |
| TASK TaskUs | Maintains: Outperform | $14 → $12 | $6.45 | +86.19% | 3 | May 7, 2026 | |
| CCRN Cross Country Healthcare | Downgrades: Neutral | $15 → $13 | $13.18 | +0.53% | 3 | May 7, 2026 | |
| RITM Rithm Capital | Maintains: Outperform | $14 → $13 | $9.84 | +27.03% | 1 | May 1, 2026 | |
| STAA STAAR Surgical Company | Maintains: Neutral | $21 → $26 | $26.69 | -2.59% | 2 | Apr 9, 2026 | |
| HLLY Holley | Initiates: Outperform | $10 | $2.82 | +254.61% | 1 | Aug 9, 2022 |
Burford Capital
May 11, 2026
Maintains: Neutral
Price Target: $4.75 → $5
Current: $5.14
Upside: -2.72%
TaskUs
May 7, 2026
Maintains: Outperform
Price Target: $14 → $12
Current: $6.45
Upside: +86.19%
Cross Country Healthcare
May 7, 2026
Downgrades: Neutral
Price Target: $15 → $13
Current: $13.18
Upside: +0.53%
Rithm Capital
May 1, 2026
Maintains: Outperform
Price Target: $14 → $13
Current: $9.84
Upside: +27.03%
STAAR Surgical Company
Apr 9, 2026
Maintains: Neutral
Price Target: $21 → $26
Current: $26.69
Upside: -2.59%
Holley
Aug 9, 2022
Initiates: Outperform
Price Target: $10
Current: $2.82
Upside: +254.61%